| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.44M | - | |
| Other | 56.4K | $9.02M | - | |
| Other | 22.4K | $3.58M | - | |
| Other | 16.2K | $2.59M | -11,170 | |
| Other | 13.3K | $2.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | Gorman Kevin Charles55 | Director | Sell | 9,613 | $120.38 | $1,157,211.02 | -1.8% | +9.3% | +27.1% | |
| May 5, 2025 | Rastetter William H48 | Director | Sale+OE | 30,000 | $110.20 | $3,305,952.00 | -44.5% | +16.7% | +23.1% | |
| Feb 14, 2025 | Roberts Eiry49 | Chief Medical Officer | Sale+OE | 2,218 | $116.44 | $258,263.73 | -2.1% | +4.6% | +7.9% | |
| Feb 13, 2025 | Gorman Kevin Charles55 | Director | Sale+OE | 5,844 | $116.69 | $681,914.46 | -0.6% | +1.6% | +6.2% | |
| Feb 13, 2025 | Sherwin Stephen A | Director | Sell | 13,831 | $116.69 | $1,613,922.79 | -56.4% | +1.6% | +6.2% | |
| Feb 13, 2025 | Onyia Jude51 | Chief Scientific Officer | Sale+OE | 2,879 | $116.79 | $336,238.63 | -7.6% | +1.6% | +6.2% | |
| Feb 13, 2025 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 2,184 | $116.75 | $254,992.44 | -2.5% | +1.6% | +6.2% | |
| Feb 13, 2025 | Cooke Julie59 | Chief Human Resources Officer | Sale+OE | 1,551 | $116.78 | $181,129.15 | -3.8% | +1.6% | +6.2% | |
| Feb 13, 2025 | Gano Kyle54 | Chief Executive Officer | Sale+OE | 2,558 | $116.85 | $298,908.05 | -0.9% | +1.6% | +6.2% | |
| Feb 13, 2025 | Delaet Ingrid66 | Chief Regulatory Officer | Sale+OE | 1,471 | $116.71 | $171,674.12 | -14.3% | +1.6% | +6.2% |